EA200971123A1 - Мультиплексный способ выявления инфекции - Google Patents

Мультиплексный способ выявления инфекции

Info

Publication number
EA200971123A1
EA200971123A1 EA200971123A EA200971123A EA200971123A1 EA 200971123 A1 EA200971123 A1 EA 200971123A1 EA 200971123 A EA200971123 A EA 200971123A EA 200971123 A EA200971123 A EA 200971123A EA 200971123 A1 EA200971123 A1 EA 200971123A1
Authority
EA
Eurasian Patent Office
Prior art keywords
multiplex
identification method
infection
microorganism
infection identification
Prior art date
Application number
EA200971123A
Other languages
English (en)
Other versions
EA017206B1 (ru
Inventor
Кристин Шарпентье
Стефан Гаделль
Надин Ламбер
Ампаро Санхуан
Original Assignee
Био-Рад Пастеэр
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Био-Рад Пастеэр filed Critical Био-Рад Пастеэр
Publication of EA200971123A1 publication Critical patent/EA200971123A1/ru
Publication of EA017206B1 publication Critical patent/EA017206B1/ru

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/02—Hepadnaviridae, e.g. hepatitis B virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/085—Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus
    • G01N2333/10—Hepatitis A virus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Изобретение относится к способу диагностического выявления in vitro инфицирования микроорганизмом, предусматривающему размещение биологического образца, в одном аналитическом сосуде, в присутствии частиц, несущих по меньшей мере один специфичный выявляемый физический параметр и принадлежащих по меньшей мере двум различным группам, одна из групп несет иммобилизованное антитело против IgM, а другая группа несет иммобилизованный антиген, полученный из указанного микроорганизма.
EA200971123A 2007-06-08 2008-06-06 Мультиплексный способ выявления инфекции EA017206B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0755626A FR2917173B1 (fr) 2007-06-08 2007-06-08 Procede multiplexe de detection d'une infection
US92906107P 2007-06-11 2007-06-11
PCT/EP2008/057111 WO2008148883A1 (en) 2007-06-08 2008-06-06 Multiplex method for detecting an infection

Publications (2)

Publication Number Publication Date
EA200971123A1 true EA200971123A1 (ru) 2010-06-30
EA017206B1 EA017206B1 (ru) 2012-10-30

Family

ID=38457970

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200971123A EA017206B1 (ru) 2007-06-08 2008-06-06 Мультиплексный способ выявления инфекции

Country Status (9)

Country Link
US (2) US20100151445A1 (ru)
EP (1) EP2160605B1 (ru)
JP (1) JP5216852B2 (ru)
CN (1) CN101711361B (ru)
BR (1) BRPI0812771B8 (ru)
CA (1) CA2687827C (ru)
EA (1) EA017206B1 (ru)
FR (1) FR2917173B1 (ru)
WO (1) WO2008148883A1 (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9689044B2 (en) 2011-01-26 2017-06-27 The Brigham And Women's Hospital, Inc. Assays and methods to sequence microbes directly from immune complexes
WO2014118775A1 (en) * 2013-01-29 2014-08-07 Bio-Rad Haifa Ltd Detection assays employing magnetic nanoparticles
WO2014176535A1 (en) * 2013-04-26 2014-10-30 Bio-Rad Laboratories, Inc. Multiplex hepatitis b assay
CN104714028B (zh) * 2015-03-02 2017-01-25 深圳市凯瑞德生物技术有限公司 一种检测IgM抗体的免疫检测方法
BR112017019236A2 (pt) 2015-03-10 2018-04-24 Bio Rad Laboratories kit, e, método para detectar a presença de anticorpos de sífilis em uma amostra
US11209431B2 (en) 2015-10-06 2021-12-28 Bio-Rad Laboratories, Inc. Borrelia immunoassays and materials therefor
CN108351351B (zh) 2015-11-09 2021-10-29 生物辐射实验室股份有限公司 使用亲和素和生物素的试验
EP3508849B1 (en) * 2016-08-31 2023-04-19 Eiken Kagaku Kabushiki Kaisha Antibody measurement method using antigen-carrying insoluble carrier particles on which antigen is immobilized by different methods, and reagent for antibody measurement
ES2929392T3 (es) * 2017-03-01 2022-11-28 Hoffmann La Roche Sistemas, procedimiento y medio legible por ordenador para clasificar una muestra biológica con respecto a la presencia de un analito
WO2020023901A1 (en) * 2018-07-27 2020-01-30 Veravas, Inc. Method for detecting biomarkers
WO2021030935A1 (zh) * 2019-08-16 2021-02-25 深圳迈瑞生物医疗电子股份有限公司 全新型总抗体测定的免疫分析模式
WO2021203044A2 (en) * 2020-04-03 2021-10-07 Icahn School Of Medicine At Mount Sinai High-throughput assay for circulating antibodies against severe acute respiratory syndrome coronavirus 2
CN115397465A (zh) * 2020-04-24 2022-11-25 美国西门子医学诊断股份有限公司 用于针对抗体的免疫测定的校准和质量控制试剂

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1172561A (en) 1981-01-28 1984-08-14 Richard H. Decker Igm detection method
DE3662730D1 (en) * 1985-01-24 1989-05-11 Inst Int Pathologie Cellulaire Immunoassay method for antibodies of different classes in a liquid sample
JPS6270764A (ja) * 1985-03-08 1987-04-01 Sanko Junyaku Kk 血清中の免疫抗体測定方法
EP0304238A3 (en) * 1987-08-14 1991-10-09 Ortho Diagnostic Systems Inc. Method for detecting and confirming the presence of antibodies
JPH05133952A (ja) * 1991-04-03 1993-05-28 Syntex Usa Inc イムノグロブリン類のイムノアツセイ
EP0507587A3 (en) * 1991-04-03 1993-03-03 Syntex (U.S.A.) Inc. Immunoassay for immunoglubulins
WO1999026067A1 (en) * 1997-11-18 1999-05-27 Bio-Rad Laboratories, Inc. Multiplex flow immunoassays with magnetic particles as solid phase
ITTO980473A1 (it) * 1998-06-02 1999-12-02 Sorin Diagnostics S R L Nuovo procedimento per la rivelazione di anticorpi e/o isotipi di anticorpi specifici per almeno due differenti fasi di un'infezione
AU2001249444A1 (en) * 2000-03-28 2001-10-08 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Methods and compositions for the simultaneous detection of multiple analytes
JP2002310875A (ja) * 2001-04-16 2002-10-23 National Institute Of Advanced Industrial & Technology 梅毒検査試薬及び梅毒検査方法
WO2003093511A1 (en) * 2002-04-30 2003-11-13 Merck & Co., Inc. Human papillomavirus multiplexed assay
FR2839555B1 (fr) * 2002-05-10 2007-07-27 Bio Rad Pasteur Procede de detection simultanee d'un antigene et d'un anticorps d'un microorganisme infectieux
CN1164948C (zh) * 2002-06-06 2004-09-01 成都夸常科技有限公司 一种基于抗原抗体反应的试剂盒
CN1902496A (zh) * 2003-11-07 2007-01-24 赫普金尼克斯股份有限公司 结合测定组分

Also Published As

Publication number Publication date
US20130273525A1 (en) 2013-10-17
BRPI0812771B1 (pt) 2019-01-22
CN101711361A (zh) 2010-05-19
CA2687827C (en) 2017-08-29
EP2160605B1 (en) 2017-11-01
JP5216852B2 (ja) 2013-06-19
WO2008148883A1 (en) 2008-12-11
CA2687827A1 (en) 2008-12-11
EA017206B1 (ru) 2012-10-30
JP2010529443A (ja) 2010-08-26
CN101711361B (zh) 2016-08-31
FR2917173A1 (fr) 2008-12-12
US9523685B2 (en) 2016-12-20
US20100151445A1 (en) 2010-06-17
BRPI0812771A2 (pt) 2014-12-02
EP2160605A1 (en) 2010-03-10
FR2917173B1 (fr) 2009-07-31
BRPI0812771B8 (pt) 2021-07-27

Similar Documents

Publication Publication Date Title
EA200971123A1 (ru) Мультиплексный способ выявления инфекции
MX2009013388A (es) Analisis multiple de muestras de sangre.
Houghton et al. Development of a prototype lateral flow immunoassay (LFI) for the rapid diagnosis of melioidosis
NZ701380A (en) Multiplex immuno screening assay
CY1119972T1 (el) Προσδιορισμος για αντισωματα ιου jc
WO2011136624A3 (ko) 자기장 인가부를 구비한 생물학적 시료 자동정제장치, 생물학적 시료로부터 타겟물질을 추출하는 방법, 그리고 단백질 발현 및 정제 방법
NZ609363A (en) Methods for determining anti-drug antibody isotypes
MX2008006945A (es) Biosensor de deteccion de patogeno.
DE60326336D1 (de) Vorrichtung und verfahren um gleichzeitig verschiedene antikörper und antigene nachzuweisen in klinischen, nahrungsmittel- und umwelt-proben
EP1982993A3 (en) Detection of primary infections with pathogens
FR2935384B1 (fr) Procede de detection du virus de la rougeole, dispositif et kit utilisant ce procede
Zhang et al. Molecular methods for pathogenic bacteria detection and recent advances in wastewater analysis
ATE526583T1 (de) Immunomagnetische erfassung und abbildung biologischer zielmoleküle
DE602006018432D1 (de) Antigennachweis
RU2014122607A (ru) Способы определения восприимчивости пациента к внутрибольничной инфекции и составления прогноза развития септического синдрома
WO2012103337A3 (en) Assays and methods to sequence microbes directly from immune complexes
WO2008152528A3 (en) Method for the diagnosis or the screening of an arbovirus infection, reagents useful in said method and their applications
RU2011140006A (ru) Способ детекции вещества в биологическом образце
FI20012603A0 (fi) Diagnostinen menetelmä
MX2020009282A (es) Análisis de patógenos en formato múltiple basado en microarreglos y usos del mismo.
RU2009124225A (ru) Мышиные моноклональные антитела, связывающиеся с антигеном f1 из yersinia pestis, способ их получения с использованием дрожжей, способ и набор для детекции yersinia pestis
Sanderson et al. The platelet fraction is a novel reservoir to detect Lyme Borrelia in blood
WO2009117469A3 (en) Examination device for blood detection
GB0706558D0 (en) Diagnostic assay
Gahlawat et al. Advances in Animal Disease Diagnosis

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

PC4A Registration of transfer of a eurasian patent by assignment